J P M O R G A N North America Equity Research 23 July 2026 Thermo Fisher Scientific 2Q26 First Take: Strong 2Q Beat Driven by Analytical Instruments This morning, Thermo Fisher (TMO) reported (press release/non-GAAP reconciliations) 2Q26 results that came in above the Street on both the top and bottom-line, with revenues of $11.99B (vs. Street of $11.70B) representing +5.0% organic growth (vs. Street of +3.0% and guide of ~+3.0%) and reported growth of +10% (+5.0% M&A and +1.0% FX impact). By segment, LSS g ...